The Children’s Inn at NIH Announces $1 Million Grant From Gilead Sciences, Inc.

On November 22, 2024 The Children’s Inn at the National Institutes of Health (NIH) reported that Gilead Sciences Inc. has awarded The Inn a $1 million grant to support its renovation and expansion (Press release, Gilead Sciences, NOV 22, 2024, View Source [SID1234648584]). The grant will fund a welcome center in the new wing of The Inn of Tomorrow, a $50-plus million project for which The Inn recently held a groundbreaking ceremony. As the first point of contact, The Gilead Sciences Welcome Center is designed to ensure young patients from around the world participating in groundbreaking clinical trials at NIH feel welcomed immediately upon their arrival at The Inn.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"Gilead is a valued partner whose therapeutic interests have intersected with The Inn’s since our beginning. With this grant, we look forward to transforming our space with new capabilities to support young patients, their families, and NIH researchers at every step along the journey from hopes to cures."

"We are grateful for Gilead’s continuing partnership with The Inn," said Jennie Lucca, The Inn’s CEO. "Gilead is a valued partner whose therapeutic interests have intersected with The Inn’s since our beginning. With this grant, we look forward to transforming our space with new capabilities to support young patients, their families, and NIH researchers at every step along the journey from hopes to cures."

A commitment to health equity and equitable access to NIH pediatric clinical trials are driving forces behind The Inn of Tomorrow. The Inn seeks to remove barriers to potentially lifesaving clinical research studies for diverse families, ensure all families find a "place like home" at The Inn by designing culturally inclusive programs, and use the health equity lens to determine how environment helps patients in their journey to optimal health.

"Gilead is proud to work with The Children’s Inn on their ongoing efforts to provide essential support services to these young patients and their families," said Carmen Villar, Vice President, ESG and Corporate Citizenship, Gilead Sciences. "Our contribution demonstrates our continued commitment to supporting communities and advancing health equity."

Construction on the project is scheduled to start in early 2025. In addition to the new welcome center in the 15,000-square-foot addition, The Inn of Tomorrow will incorporate improved accessibility features throughout, resulting in a state-of-the-art residential facility that reflects best practices in healthcare and hospitality. When completed in 2027, the project will expand The Inn’s capacity to serve more and younger patients – increasing annual capacity by 25% from 2,400 to 3,000 families.